Benchmark Holdings - Investor Presentation (Q1 Results) - February 2024

Trond Williksen, CEO, and Septima Maguire, CFO of Benchmark Holdings hosted an Investor Presentation following publication of their Q1 results for the period to 31 Dec 2023.
Revenues were £40.5m for the quarter, 26% below a particularly strong Q1 FY23, but 11% above Q4 FY23, maintaining quarterly momentum. In Genetics, management discussed solid performance in the core salmon business and progress in growth vectors. In Advanced Nutrition, the company posted strong performance in Europe and in the Health division significant steps have been taken to transition to new business model for Ectosan® Vet and CleanTreat®.
Watch the full presentation (dividend into chapters for ease of viewing, as below) for more details on period highlights and operational performance per division, including a Financial overview and an update on Outlook.
Timestamps:
0:00:00 Introduction
0:00:36 Overview of Q1 & period highlights
0:05:40 Operational Update - Genetics
0:13:28 Operational Update - Advanced Nutrition
0:17:47 Operational Update - Health
0:23:46 Financial Update
0:30:26 Outlook
0:33:23 Questions & Answers